Furthermore, gene expression analysis has confirmed that HER2-low breast cancers have a decreased expression of proliferation-related genes, tyrosine kinase receptor genes [4, 21], and androgen receptor [35]. The gene discussed is NTRK1; the disease is breast carcinoma.